Literature DB >> 15325793

Functional microtubules are required for antigen processing by macrophages and dendritic cells.

Kristina K Peachman1, Mangala Rao, Dupeh R Palmer, Michael Zidanic, Wellington Sun, Carl R Alving, Stephen W Rothwell.   

Abstract

Antigen-presenting cells readily phagocytose antigens and channel them through various membrane-bound organelles within the cell. In previous studies, we demonstrated that macrophages concentrated and localized particulate antigens to the trans-Golgi prior to displaying the MHC-class I-antigenic peptides on the cell surface. In this study, we evaluated the importance of cytoskeletal elements in the intracellular trafficking of soluble and liposome-encapsulated ovalbumin in murine bone marrow-derived macrophages and human dendritic cells. F-actin, as identified by staining with fluorescein phalloidin, was observed at the point of contact between soluble or liposomal antigen and the cell membrane, suggesting that a rearrangement of the cytoskeleton occurs to facilitate the uptake of the antigens. Cells were incubated with colchicine, a microtubule depolymerizing agent, or paclitaxel, a microtubule polymerizing agent, before the addition of Texas Red-labeled ovalbumin or liposome-encapsulated Texas Red-labeled ovalbumin. Colchicine disrupted the trans-Golgi, whereas the trans-Golgi complexes were intact in paclitaxel treated cells. In either paclitaxel or colchicine-treated macrophages, internalized liposomal ovalbumin was not concentrated in the area of the trans-Golgi as determined by staining with fluorescent ceramide. In contrast, soluble ovalbumin was concentrated in the region of the trans-Golgi in 15% of the dendritic cells treated with paclitaxel, whereas 6% of the dendritic cells were able to concentrate liposomal antigen. In colchicine-treated dendritic cells, both soluble and liposomal antigens were internalized but did not localize to the area of the trans-Golgi. These data suggest that trafficking of soluble and liposome-encapsulated ovalbumin requires a functional microtubule-dependent translocation system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15325793     DOI: 10.1016/j.imlet.2004.05.013

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  8 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages.

Authors:  Edward W Eng; Adam Bettio; John Ibrahim; Rene E Harrison
Journal:  Mol Biol Cell       Date:  2007-04-18       Impact factor: 4.138

3.  Proteomic analysis of microtubule-associated proteins during macrophage activation.

Authors:  Prerna C Patel; Katherine H Fisher; Eric C C Yang; Charlotte M Deane; Rene E Harrison
Journal:  Mol Cell Proteomics       Date:  2009-08-02       Impact factor: 5.911

Review 4.  Colchicine--Update on mechanisms of action and therapeutic uses.

Authors:  Ying Ying Leung; Laura Li Yao Hui; Virginia B Kraus
Journal:  Semin Arthritis Rheum       Date:  2015-06-26       Impact factor: 5.532

5.  A microfluidic-based genetic screen to identify microbial virulence factors that inhibit dendritic cell migration.

Authors:  Laura M McLaughlin; Hui Xu; Sarah E Carden; Samantha Fisher; Monique Reyes; Sarah C Heilshorn; Denise M Monack
Journal:  Integr Biol (Camb)       Date:  2014-03-06       Impact factor: 2.192

6.  Effects of Colchicine on Atherosclerotic Plaque Stabilization: a Multimodality Imaging Study in an Animal Model.

Authors:  Alberto Cecconi; Jean Paul Vilchez-Tschischke; Jesus Mateo; Javier Sanchez-Gonzalez; Samuel España; Rodrigo Fernandez-Jimenez; Beatriz Lopez-Melgar; Leticia Fernández Friera; Gonzalo J López-Martín; Valentin Fuster; Jesus Ruiz-Cabello; Borja Ibañez
Journal:  J Cardiovasc Transl Res       Date:  2020-03-05       Impact factor: 4.132

7.  Specific microtubule-depolymerizing agents augment efficacy of dendritic cell-based cancer vaccines.

Authors:  Chih-Chun Wen; Hui-Ming Chen; Swey-Shen Chen; Li-Ting Huang; Wei-Ting Chang; Wen-Chi Wei; Li-Chen Chou; Palanisamy Arulselvan; Jin-Bin Wu; Sheng-Chu Kuo; Ning-Sun Yang
Journal:  J Biomed Sci       Date:  2011-06-20       Impact factor: 8.410

Review 8.  Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy.

Authors:  Esther Forkosh; Ariel Kenig; Yaron Ilan
Journal:  Pharmacol Res Perspect       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.